Agile Therapeutics Launches I’m So Done Campaign to Inspire Women to Take an Active Role in Choosing their Birth Control
September 02 2020 - 9:00AM
Agile Therapeutics, Inc. (Nasdaq: AGRX), a forward-thinking
women’s healthcare company, today announced the launch of I’m So
Done, an education and empowerment platform that encourages women
to think about their current contraceptive method and
decision-making journey.
"We are excited to launch I’m So Done, a
new digital-first campaign to help women recognize that they have
the right to be an active participant in selecting contraceptive
care that suits their lifestyle,” said Al Altomari, Chairman and
Chief Executive Officer of Agile Therapeutics.
Agile Therapeutics Vice President of Marketing
Amy Welsh added, “We believe that finding the right contraceptive
method is an important factor in sexual and reproductive health.
Yet, despite the availability of a wide range of birth control
options, many women struggle to determine which method is the best
fit for them. I’m So Done will provide education and encouragement
for women to take a more empowered and informed role in shared
decision-making with her healthcare provider about birth
control.”
I’m So Done features a balanced discussion of
the spectrum of contraceptive methods, helping women to explore
their options. The campaign is designed to encourage a two-way
dialogue between women and their healthcare providers about sexual
health as well as contraceptive practices and concerns. In addition
to education, I’m So Done provides a safe place for women to
discuss their experiences, with the reassurance that they are not
alone, on the @SoDoneClub Facebook and Instagram
pages.
“Women stay on a method longer if it is a method
of their choosing and contraceptive education is critical to
informing choice,” said Deborah Arrindell, VP of Health Policy at
the American Sexual Health Association. “According to the
Guttmacher Institute, a woman who wants two children will use
contraception for about three decades. Women need different options
throughout their lives, and we welcome a platform like I’m So Done
to help women learn about contraceptive choice for their
lifestyle.”
Visit BirthControlDoneMyWay.com to see how real
women are responding to a poll about birth control, and to find
helpful information and tools outlining the pros and cons of
various contraceptive methods.
About Agile Therapeutics,
Inc.
Agile Therapeutics is a women's healthcare
company dedicated to fulfilling the unmet health needs of today’s
women. Our product candidates are designed to provide women with
contraceptive options that offer freedom from taking a daily pill,
without committing to a longer-acting method. Our initial product,
Twirla®, (levonorgestrel and ethinyl estradiol) transdermal system
is a non-daily prescription contraceptive. Twirla is based on our
proprietary transdermal patch technology, called Skinfusion®, which
is designed to allow drug delivery through the skin. For more
information, please visit the company website
at www.agiletherapeutics.com. The Company may
occasionally disseminate material, nonpublic information on the
Company’s website.
Follow Agile
on LinkedIn and
Twitter: @AgileTher.
Source: Agile Therapeutics
Contact: Matt RileyHead of
Investor Relations & Corporate
Communicationsmriley@agiletherapeutics.com
Photos accompanying this announcement are available
at:https://www.globenewswire.com/NewsRoom/AttachmentNg/7fb10a4e-a77d-42df-8d4e-96915ea04c40
https://www.globenewswire.com/NewsRoom/AttachmentNg/886f9d45-2994-4ea3-a814-1ae0e4d062a9
Agile Therapeutics (NASDAQ:AGRX)
Historical Stock Chart
From Aug 2024 to Sep 2024
Agile Therapeutics (NASDAQ:AGRX)
Historical Stock Chart
From Sep 2023 to Sep 2024